Fate Therapeutics, Inc.
NASDAQ: FATE
$32.42
Closing price August 10, 2022
The American Society of Hematology (ASH) hosted its 61st annual meeting and one of the biggest biotech events earlier this week in Orlando, Florida.
2 years ago
Last Updated: 2 years ago
Fate Therapeutics shares jumped on Monday after the firm announced new preclinical data for its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal...
2 years ago
Last Updated: 2 years ago
Tuesday's top analyst upgrades, downgrades and initiations included Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron Technology, PG&E, Snap and VMWare.
2 years ago
Last Updated: 2 years ago
Get Our Free Investment Newsletter